Patient perspectives on repeated MRI and PET/CT examinations during neoadjuvant treatment of esophageal cancer.
Lucas GoenseAlicia S BorggreveSophie E HeethuisAstrid Lhmw van LierRichard van HillegersbergStella MookGert J MeijerPeter S N van RossumJelle P RuurdaPublished in: The British journal of radiology (2018)
Repeated imaging with both MRI and PET/CT is generally well-tolerated for the assessment of response to treatment in esophageal cancer patients. Shorter acquisition times and altered body positioning during scanning will likely improve patient experience. Advances in knowledge: This paper demonstrates that MRI and PET/CT are generally well-tolerated imaging procedures for the assessment of response to treatment in esophageal cancer patients. When asked to rank different tests, patients preferred MRI over PET/CT and endoscopy.